{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:26:39Z","timestamp":1740633999351,"version":"3.38.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1124\/mol.114.091736","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T05:16:06Z","timestamp":1396502166000},"page":"921-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pro32Pro33 Mutations in the Integrin \u03b23 PSI Domain Result in \u03b1IIb\u03b23 Priming and Enhanced Adhesion: Reversal of the Hypercoagulability Phenotype by the Src Inhibitor SKI-606"],"prefix":"10.1016","volume":"85","author":[{"given":"Kendra H.","family":"Oliver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily L.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Y.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.114.091736_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00001721-200401000-00014","article-title":"PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation","volume":"15","author":"Angiolillo","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1124\/mol.114.091736_bib2","doi-asserted-by":"crossref","first-page":"13298","DOI":"10.1073\/pnas.2336149100","article-title":"Src kinase activation by direct interaction with the integrin beta cytoplasmic domain","volume":"100","author":"Arias-Salgado","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.091736_bib3","doi-asserted-by":"crossref","first-page":"29699","DOI":"10.1074\/jbc.M503508200","article-title":"Specification of the direction of adhesive signaling by the integrin beta cytoplasmic domain","volume":"280","author":"Arias-Salgado","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib4","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1182\/blood.V93.9.2959.409k20_2959_2967","article-title":"Construction of a human platelet alloantigen-1a epitope(s) within murine glycoprotein IIIa: identification of residues critical to the conformation of the antibody binding site(s)","volume":"93","author":"Barron-Casella","year":"1999","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cyto.10114","article-title":"Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody","volume":"48","author":"Bergmeier","year":"2002","journal-title":"Cytometry"},{"key":"10.1124\/mol.114.091736_bib6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/jm000420z","article-title":"Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles","volume":"44","author":"Boschelli","year":"2001","journal-title":"J Med Chem"},{"key":"10.1124\/mol.114.091736_bib7","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1182\/blood-2012-01-406322","article-title":"Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of \u03b1IIb\/\u03b23 integrin","volume":"119","author":"Bougie","year":"2012","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1648803","article-title":"Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb\/IIIa complex","volume":"72","author":"Calvete","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1124\/mol.114.091736_bib9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI33374","article-title":"Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans","volume":"118","author":"Carneiro","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.114.091736_bib10","doi-asserted-by":"crossref","first-page":"20567","DOI":"10.1016\/S0021-9258(17)32031-8","article-title":"A transmembrane-anchored chimeric focal adhesion kinase is constitutively activated and phosphorylated at tyrosine residues identical to pp125FAK","volume":"269","author":"Chan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2004.11.015","article-title":"A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy","volume":"338","author":"Chen","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.114.091736_bib12","first-page":"147","article-title":"Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK","volume":"14","author":"Cobb","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.114.091736_bib13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1160\/TH05-05-0359","article-title":"Anti-thrombotic action of clopidogrel and P1(A1\/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin","volume":"94","author":"Dropinski","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1124\/mol.114.091736_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/jth.12209","article-title":"C560R\u03b23 caused platelet integrin \u03b1II b \u03b23 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality","volume":"11","author":"Fang","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1124\/mol.114.091736_bib15","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2007-09-112615","article-title":"A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia","volume":"111","author":"Ghevaert","year":"2008","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib16","first-page":"375","article-title":"SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice","volume":"63","author":"Golas","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/mol.114.091736_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0735-1097(00)00710-5","article-title":"PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications","volume":"36","author":"Goldschmidt-Clermont","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/mol.114.091736_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1126\/science.1174779","article-title":"G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin \u201coutside-in\u201d signaling","volume":"327","author":"Gong","year":"2010","journal-title":"Science"},{"key":"10.1124\/mol.114.091736_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/euhj.1998.1203","article-title":"Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease","volume":"20","author":"Goodall","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1124\/mol.114.091736_bib20","doi-asserted-by":"crossref","first-page":"e47304","DOI":"10.1371\/journal.pone.0047304","article-title":"Modeling and molecular dynamics of HPA-1a and -1b polymorphisms: effects on the structure of the \u03b23 subunit of the \u03b1IIb\u03b23 integrin","volume":"7","author":"Jallu","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/mol.114.091736_bib21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/j.1538-7836.2012.04856.x","article-title":"Identification of Hic-5 as a novel regulatory factor for integrin \u03b1IIb\u03b23 activation and platelet aggregation in mice","volume":"10","author":"Kim-Kaneyama","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1124\/mol.114.091736_bib22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ahj.2007.05.021","article-title":"Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction","volume":"154","author":"Knowles","year":"2007","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"10.1124\/mol.114.091736_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1423-0410.2002.tb05274.x","article-title":"The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis","volume":"83","author":"Kunicki","year":"2002","journal-title":"Vox Sang"},{"key":"10.1124\/mol.114.091736_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4161\/cam.20488","article-title":"Integrin adhesions: who\u2019s on first? What\u2019s on second? Connections between FAK and talin","volume":"6","author":"Lawson","year":"2012","journal-title":"Cell Adhes Migr"},{"key":"10.1124\/mol.114.091736_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.thromres.2006.02.006","article-title":"Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel","volume":"119","author":"Lev","year":"2007","journal-title":"Thromb Res"},{"key":"10.1124\/mol.114.091736_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","article-title":"Arterial thrombus formation in cardiovascular disease","volume":"8","author":"Lippi","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/mol.114.091736_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/meth.2000.1006","article-title":"Evaluation of platelet function by flow cytometry","volume":"21","author":"Michelson","year":"2000","journal-title":"Methods"},{"key":"10.1124\/mol.114.091736_bib28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.101.9.1013","article-title":"Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists","volume":"101","author":"Michelson","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/mol.114.091736_bib29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1160\/TH07-04-0248","article-title":"Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3","volume":"98","author":"Mor-Cohen","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1124\/mol.114.091736_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm1722","article-title":"Kindlin-3 is essential for integrin activation and platelet aggregation","volume":"14","author":"Moser","year":"2008","journal-title":"Nat Med"},{"key":"10.1124\/mol.114.091736_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MBC.0b013e328325455b","article-title":"High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial","volume":"20","author":"Motovska","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1124\/mol.114.091736_bib32","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.114.091736_bib33","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1084\/jem.20071827","article-title":"Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo","volume":"204","author":"Nieswandt","year":"2007","journal-title":"J Exp Med"},{"key":"10.1124\/mol.114.091736_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1083\/jcb.200112113","article-title":"Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton","volume":"157","author":"Obergfell","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.114.091736_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/bj3550691","article-title":"Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2","volume":"355","author":"Osada","year":"2001","journal-title":"Biochem J"},{"key":"10.1124\/mol.114.091736_bib36","first-page":"d143","article-title":"Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration","volume":"7","author":"Panetti","year":"2002","journal-title":"Front Biosci"},{"key":"10.1124\/mol.114.091736_bib37","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1538-7836.2005.01418.x","article-title":"Therapeutic approaches in arterial thrombosis","volume":"3","author":"Phillips","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1124\/mol.114.091736_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood-2008-09-180604","article-title":"Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia","volume":"114","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/leu.2008.334","article-title":"Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells","volume":"23","author":"Remsing Rix","year":"2009","journal-title":"Leukemia"},{"key":"10.1124\/mol.114.091736_bib40","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/mol.114.091736_bib41","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood.V98.8.2432","article-title":"A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype","volume":"98","author":"Ruiz","year":"2001","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib42","first-page":"1680","article-title":"Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src","volume":"14","author":"Schaller","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.114.091736_bib43","doi-asserted-by":"crossref","first-page":"32479","DOI":"10.1016\/S0021-9258(18)31660-0","article-title":"Tyrosine kinases regulate the cytoskeletal attachment of integrin alpha IIb beta 3 (platelet glycoprotein IIb\/IIIa) and the cellular retraction of fibrin polymers","volume":"269","author":"Schoenwaelder","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1083\/jcb.201112128","article-title":"FAK and talin: who is taking whom to the integrin engagement party?","volume":"196","author":"Serrels","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.114.091736_bib45","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1538-7836.2012.04814.x","article-title":"Distinct and overlapping functional roles of Src family kinases in mouse platelets","volume":"10","author":"S\u00e9verin","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1124\/mol.114.091736_bib46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.V98.4.1055","article-title":"Variable protection of beta 3-integrin\u2014deficient mice from thrombosis initiated by different mechanisms","volume":"98","author":"Smyth","year":"2001","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.1086652","article-title":"Talin binding to integrin beta tails: a final common step in integrin activation","volume":"302","author":"Tadokoro","year":"2003","journal-title":"Science"},{"key":"10.1124\/mol.114.091736_bib48","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/hc4701.099787","article-title":"Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury","volume":"104","author":"Undas","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/mol.114.091736_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/asheducation-2009.1.267","article-title":"Antiplatelet agents","volume":"2009","author":"Varon","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1124\/mol.114.091736_bib50","doi-asserted-by":"crossref","first-page":"33623","DOI":"10.1074\/jbc.M704107200","article-title":"Dynamic interaction between Src and C-terminal Src kinase in integrin alphaIIbbeta3-mediated signaling to the cytoskeleton","volume":"282","author":"Vielreicher","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-5793(03)00170-4","article-title":"Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3","volume":"540","author":"Vijayan","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.114.091736_bib52","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1074\/jbc.M208680200","article-title":"Enhanced activation of mitogen-activated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin beta 3","volume":"278","author":"Vijayan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib53","doi-asserted-by":"crossref","first-page":"33039","DOI":"10.1074\/jbc.C400239200","article-title":"Protein phosphatase 1 associates with the integrin alphaIIb subunit and regulates signaling","volume":"279","author":"Vijayan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib54","doi-asserted-by":"crossref","first-page":"21756","DOI":"10.1074\/jbc.M500872200","article-title":"The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine\/threonine phosphatases","volume":"280","author":"Vijayan","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib55","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1073\/pnas.040548197","article-title":"A structural basis for integrin activation by the cytoplasmic tail of the alpha IIb-subunit","volume":"97","author":"Vinogradova","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.091736_bib56","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/blood.V82.11.3386.3386","article-title":"Amino acid 489 is encoded by a mutational \u201chot spot\u201d on the beta 3 integrin chain: the CA\/TU human platelet alloantigen system","volume":"82","author":"Wang","year":"1993","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib57","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1182\/blood.V92.9.3260","article-title":"Adhesive and signaling properties of a naturally occurring allele of glycoprotein IIIa with an amino acid substitution within the ligand binding domain-the Pena\/Penb platelet alloantigenic epitopes","volume":"92","author":"Wang","year":"1998","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2006.10.048","article-title":"Structural basis of integrin activation by talin","volume":"128","author":"Wegener","year":"2007","journal-title":"Cell"},{"key":"10.1124\/mol.114.091736_bib59","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood-2012-07-440644","article-title":"Structural framework of c-Src activation by integrin \u03b23","volume":"121","author":"Xiao","year":"2013","journal-title":"Blood"},{"key":"10.1124\/mol.114.091736_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1091\/mbc.5.4.413","article-title":"Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain","volume":"5","author":"Xing","year":"1994","journal-title":"Mol Biol Cell"},{"key":"10.1124\/mol.114.091736_bib61","doi-asserted-by":"crossref","first-page":"40252","DOI":"10.1074\/jbc.C400362200","article-title":"A novel adaptation of the integrin PSI domain revealed from its crystal structure","volume":"279","author":"Xiong","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.091736_bib62","doi-asserted-by":"crossref","first-page":"17729","DOI":"10.1073\/pnas.0909589106","article-title":"Structure of an integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation","volume":"106","author":"Yang","year":"2009","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2403935X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2403935X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.114.091736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T17:32:39Z","timestamp":1740591159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2403935X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0026895X2403935X"],"URL":"https:\/\/doi.org\/10.1124\/mol.114.091736","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro32Pro33 Mutations in the Integrin \u03b23 PSI Domain Result in \u03b1IIb\u03b23 Priming and Enhanced Adhesion: Reversal of the Hypercoagulability Phenotype by the Src Inhibitor SKI-606","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.114.091736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}